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Abstract
We have applied a little-known data transformation to subsets of the Surveillance,
Epidemiology, and End Results (SEER) publically available data of the National Cancer
Institute (NCI) to make it suitable input to standard machine learning classifiers. This
transformation properly treats the right-censored data in the SEER data and the
resulting Random Forest and Multi-Layer Perceptron models predict full survival curves.
Treating the 6, 12, and 60 months points of the resulting survival curves as 3 binary
classifiers, the 18 resulting classifiers have AUC values ranging from .765 to .885.
Further evidence that the models have generalized well from the training data is
provided by the extremely high levels of agreement between the random forest and
neural network models predictions on the 6, 12, and 60 month binary classifiers.
1 Introduction
Opportunities are emerging in many industries today to develop and deploy services
that cater to individual needs and preferences. Music afficianados can create their own
radio stations from Pandora [1], bibliophiles can receive book recommendations from
goodreads.com [2], and Google will provide directions between any two points with
warnings of delays in real-time, as well as allowing users to choose the mode of
transportation [3]. These services leverage large databases to learn and extract
information relevant to individuals. A class of techniques that transforms data into
actionable information goes by the name of Machine Learning (ML) [4]. ML has
recently become a popular method to answer questions and solve problems that are too
complex to solve via traditional methods.
The primary objective of this study is to show how ML models can be trained using
publically available data to produce personalized survival prognosis curves. The
methods presented below can be applied to any type of temporal outcome data,
including survival, cost, complication and toxicity data. Traditionally, cancer survival
curves have been estimated using Kaplan-Meier methods [5]. Kaplan-Meier
methodology also uses large datasets to make predictions, but the resulting curves are
summaries for a population and not necessarily relevant or accurate for any given
individual. This property of Kaplan-Meier methods is exacerbated when dealing with
heterogeneous populations [6]. The capability to provide individualized survival curve
prognoses is a direct result of recent advances in computing power and ML algorithms.
Similar methodology is becoming commonplace in many industries. These techniques
are now infiltrating the healthcare industry.
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The Surveillance, Epidemiolgy, and End Results (SEER) Program of the National
Cancer Institute (NCI) program is the most recognized authoritative source of
information on cancer incidence and survival in the United States and is the primary
data source for this study. SEER currently collects and publishes cancer incidence and
survival data from population-based cancer registries covering approximately 28 percent
of the US population. The SEER Program has been collecting data since 1973.
Intuitively researchers feel confident that this data will surface information crucial to
patients and providers, including the relationships between the collected data
(demographics, staging, treatment and disease characteristics) and survival outcomes.
Though these relationships evade capture by traditional methods, it is possible to
surface them with two machine learning techniques known as random forests and neural
networks.
One challenge of the SEER data that is shared by many survival datasets is the
inclusion of censored data. Observations are labeled censored when the survival
information is incomplete. The SEER data contains the number of months each patient
survived, as well as the vital status. Traditional methods to deal effectively with this
kind of ”right-censored data” include Kaplan-Meier curves and Cox Proportional
Hazard models [5].
Previous work applying machine learning methods to subsets of the SEER data
include creative attempts to deal with the problems presented by right-censored data.
Shin et al. [7] use semi-supervised learning techniques to predict 5 year survival,
essentially imputing values for SEER records where the survival infomation is censored
at a value less than 5 years. Zolbanin et al. [8] remove all records corresponding to
patients who were living but censored within the 60 month study window. This
treatment biases the predictions and leads to overly pessimistic predictions.
Previous work applying machine learning methods based on decision trees to survival
data in general have a long history, starting with Gordon et al. [9]. A summary of more
recent developments concerning survival trees is provided by Bou-Hamad et al. [10].
These methods focus on altering the splitting critieria used in decision tree growth to
account for the censoring, and use Kaplan-Meier methods at the resulting nodes for
prediction purposes. These methods do not generalize to non-tree-based machine
learning algorithms, though Ishwaran et al. have extended the methodology to random
survival forests, ensembles of survival trees [11].
Instead of modifying existing learning algorithms, we focus attention on the input
data. This approach allows us to take advantage of powerful and rapidly improving
machine learning derived discrete classifiers without modification. The essential idea is
to recast the problem as a discrete classification problem (predicting the liklihood that a
patient is alive in any given month) instead of a regression problem (predicting survival
months). Treating months after diagnosis as a discrete feature, the SEER data (or any
other right-censored data) can be transformed to make predictions for the hazard
function (the probability of dying in the next month, given that the patient has not yet
died). The survival function can then be derived from the hazard function.
2 Materials and Methods
2.1 Data preparation and preprocessing
For this study we use the publically available 1973-2012 SEER incidence data files
corresponding to colon, breast and lung cancer. These files are listed in subsection (5.1).
A great deal of data munging is necessary before using these SEER incidence files as
input into machine learning algorithms. The input data was recoded and reshaped to
comply with the requirements of the analysis program. Details are included in
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subsection (5.2). Biefly, we transformed the location variables that are given as
categorical State and County code pairs to (latitude, longitude, elevation) triples using
the Google Maps API, as well as one-hot encoded all categorical variables.
In the SEER data, there is a record for each primary tumor. If multple records exist
for a given patient, only the first chronologically was included. The full set of conditions
defining the subsets of the SEER data used in this study is included in section (5.3).
Before applying machine learning models trained with these datasets, we describe in
detail a method that takes full advantage of all the data, including the right-censored
data, and which involves a simple and intuitive transformation, culminating in the full
set of features and target variable listed in sections (5.4, 5.5, 5.6).
2.2 Transformation of Censored Data for Machine Learning
In this section we describe a transformation of right-censored data. The tramsformed
data can be used as input to machine learning algorithms which learn the hazard
fuction. The full details of this transformation, and a large inspiration for this study,
can be found in this blog post [12].
The key observation is to note that the hazard function at any given time point can
be directly learned via standard machine learning methods. The hazard function can be
written as
λ(Xi, tj) = P (Y = tj |Y ≥ tj ,Xi), (1)
the probability that, if someone has survived up until month tj , they will die in that
month. j runs from 0 to 107, and Xi corresponds to the single row corresponding to
patient i in the original untransformed dataset. 107 months was the maximum value of
survival months in all three of the cancer datasets, and is a consequence of the data
subsets chosen for this study. Y represents the true, uncensored number of survival
months of the patient. What is actually provided in the SEER data is the related
variable SURVIVAL MONTHS T (how long each subject was in the study), and whether
they exited by dying or being censored (D), VITAL STATUS RECODE . D is a Boolean
variable, so D = 1 if T = Y , and D = 0 if T < Y .
It follows directly from equation (1) that
P (Y = tj |Xi) = λ(Xi, tj)
j−1∏
k=1
(1− λ(Xi, tk)) (2)
Knowing P (Y = tj |Xi) for all tj gives the full probablity distribution of dying at time
Y [12]. The survival function is then readily derived from this distribution as
S(Xi, tk) = 1− CDF (Xi, tk) (3)
where CDF (Xi, tk) =
∑k
j=1 P (Y = tj |Xi) is the cumulative density function
correponding to the probability mass function in equation (2) [13].
Treating T as just another covariate is the key to the transformation. Each
datapoint in the hidden classification problem is the combination of an Xi in the orginal
dataset plus some month tj , and the classification problem is ”did point Xi die in
month tj .” We will call this new variable Dij ( newtarget ). We can transform our
original dataset into a new one, with one row for each month that each Xi is in the
sample; train a standard classifier on this new dataset with Dij as the target, and
derive a survival model from the orginal dataset. Psuedocode for this transformation is
found in section (5.7).
Explicit examples will help make this transformation clear. The untransformed
records represented in section (5.13) are transformed to the multiple records shown in
section (5.14).
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One obvious side effect of this transformation is that it increases the length of the
dataset. For this study, the original, untransformed colon cancer DataFrame has shape
(113072, 103), and the total transformed colon cancer DataFrame has shape
(4165251, 103). Similary, the original, untransformed lung cancer DataFrame has shape
(177089, 115), and the total transformed lung cancer DataFrame has shape
(3079931, 115). The biggest increase in dataset size occured with the breast cancer data,
which is a consequence of the relatively high survival rates in breast cancer. A patient
who is censored with a recorded survival months of 48 will contribute 49 rows to the
transformed dataset. The original, untransformed breast cancer DataFrame has shape
(329949, 67), and the total transformed breast cancer DataFrame has shape
(15085711, 67). Training machine learning algorithms on such large datasets, even after
splitting into training and testing sets described below, requires large RAM. All
computations for this study were performed on a Dell XPS 8700 Desktop with 32GB of
RAM. The training times involved in the classification task of learning the hazard
function λ(Xi, tj) for the chosen model parameters were on the order of a few hours or
less, but the evaluation of the AUC performance metrics associated with the 6, 12, and
60 month binary survival classifiers took more than 24 hours for the random forest
models. These AUC performance metrics provided the feedback mechanism to adjust
the model hyperparameters.
2.3 Training and Test Partitions
The datasets were split into training and test sets at the patient level, with 97% of
patients assigned to the training set, and the remaining 3% of patients assigned to the
test set. All records corresponding to a given patient were assigned exclusively to either
the training or test set. This choice of an unusually low percentage of data in the test
set was made for two reasons. The performance metrics described in section (3.1) for
the given choice of training and test partition of the data took well over 24 hours for the
random forest models; choosing the conventional 80/20 split would have resulted in
prohibitively long times for the traning-performance metric feedback loop. Because of
the large size of the data set, this choice of training and test partition still leads to an
acceptably large test set for the purposes of model evaluation. An additional
characteristic of this transformed data that requires careful treatment involves
balancing. The transformation results in many new records with the target variable
newtarget == 0. The training and test sets must be chosen such that the ratio of the
number of records with newtarget == 0 to that of the number of records with
newtarget == 1 is the same in the training and test datasets. This ratio turns out to
be ≈ 396 for the breast cancer data, ≈ 99 for the colon cancer data, and ≈ 22.75 for the
lung cancer data. The shapes of the training and testing datasets for breast cancer used
in this study are (14936862, 67) and (148849, 67), respectively. For lung cancer, the
corresponding datasets have shapes (2988768, 115) and (91163, 115). Finallly, for colon
cancer the partition into training and test datasets of the transformed data have the
shapes (3958008, 103) and (207243, 103). Multiple rows correspond to the same test
patient in these datasets. The colon cancer test dataset represents 5654 distinct
patients; the breast cancer test dataset represents 3300 distinct patients; and the lung
test dataset contains data for 5313 distinct patients.
The models described below are trained to learn the values of newtarget , which is
a binary variable: a value of 0 indicates that the subject is still alive at the given month,
while a value of 1 indicates that the patient died at that particular value of months .
The random forests and neural networks described below are binary classifiers with the
target newtarget . Both the random forests and neural networks are capable of not
only performing strict class prediction, i.e. predicting whether newtarget is 0 or 1,
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but are also able to predict the probability of newtarget being 0 or 1, and are thus
able to learn the hazard function.
2.4 Prediction Models
With the datasets transformed as described above, we are now able to use them to train
and evaluate machine learning classifiers. The classifier models described in this section
are learning the hazard function: given all of the data given in sections (5.4, 5.5, 5.6) for
each cancer type, which includes the field months (the months after diagnosis), the
models predict the target variable newtarget , which is a binary class label equal to 1
if the subject died in that month and 0 otherwise.
From the hazard function for each unique patient, we can construct the survival
function as in Equation (3). The relevant python code is available at the github
repository containing supplemental material for this study [14]. For each patient i, all
input data minus months and newtarget is represented by Xi. After the classfier
models have trained with target newtarget on the training set, each subject’s survival
function is computed in the corresponding test set. These functions are computed by
using the model to predict λ(Xi, tj) for j running from 0 to 107 months, and Xi
corresponds to the single row corresponding to subject i in the original untransformed
dataset. 107 months was the maximum value of survival months in all three of the
cancer datasets, and is a consequence of the data subsets chosen for this study.
Decision Trees and Random Forests Decision tree classifiers are attractive
models because they can be intrepeted easily. Like the name decision tree suggests, we
can think of this model as breaking down our data by making decisions based on asking
a series of questions. Based on the features in our training set, the decision tree model
learns a series of questions to infer the class labels of the samples.
Random forests have gained huge popularity in applications of machine learning
during the last decade due to their good classification performance, scalability, and ease
of use. Intuitively, a random forest can be considered as an ensemble of decision trees.
The idea behind ensemble learning is to combine weak learners to build a more robust
model, a strong learner, that has a better generalization error and is less susceptible to
overfitting.
The goal behind ensemble methods is to combine different classifiers into a
meta-classifier that has a better generalization performance than each individual
classifier alone. For example, assuming that we collected predictions from 10 experts,
ensemble methods would allow us to strategically combine these predictions by the 10
experts to come up with a prediction that is more accurate and robust than the
predictions by each individual expert. The individual decision trees that make an
ensemble are called base learners, and as long as the error rate of each base learner is
less than .50, the combined random forest will benefit from the affects of combining
predictions to achieve a far greater accuracy.
A big advantage of random forests is that honing in on suitable hyperparameter
values (the number of trees in the forest, the depth of each decision tree, the specific
measure of information gain used to choose the node splitting, etc) is not very difficult.
The ensemble method is robust to noise from the individual decision trees, which helps
to prevent overfitting (memorizing the training dataset targets instead of generalizing
from learned rules to perform successfuly on unseen data). The only parameter that has
a clearly noticeable effect on performance is the number of trees to include in the forest;
in general, the more trees the better the performance, but there is a price to pay in
terms of computational cost. The number of trees for the forests trained in this study
was relatively small, 20 trees for breast cancer and 25 for both the lung and colon
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cancer models. We have used the Python scikit-learn implemenation of the Random
Forest machine learning classifier [15]. Random Forests are frequent winners of the
Kaggle machine learning competitions [16]. The model parameters for each cancer type
are given in sections (5.8, 5.9, 5.9).
Multi-Layer Perceptron Neural Networks Neural networks are a
biologically-inspired programming paradigm that enables computers to learn from
observational data [17]. The pharmaceutical industry recently started to use deep
learning techniques for drug discovery and toxicity prediction, and research has shown
that these novel techniques substantially exceed the performance of traditional methods
for virtual screening [18].
We have used the Multi-Layer Perceptron Neural Network (MLP neural network)
implementation Keras developed at MIT. Keras was initially developed as part of the
research effort of project ONEIROS (Open-ended Neuro-Electronic Intelligent Robot
Operating System) [19]. Keras is a minimalist, highly modular neural networks library,
written in Python and capable of running on top of either TensorFlow or Theano. The
model architecture for each cancer type is given in sections (5.10, 5.11, 5.12).
3 Results
In order to evaluate the performance of the models, we first construct three binary
classifiers corresponding to whether or not a subject survived 6, 12, or 60 months after
diagnosis. We iterate over all distinct patient indices in the test set, compute the
predicted survival function, and capture the values corresonding to 6, 12, and 60
months. If the survival function evaluted at 6 months is greater than or equal to .5 for a
given patient, then the 6 months binary classifier predicts that that patient will be alive
6 months after diagnosis. Similarly, if the survival function evaluted at 12 months is less
than .5, then the 12 months binary classifier predicts that that subject will be dead 12
months after diagnosis. Fig. (1) illustrates the method; in this case the 6-month and
12-month classifiers predict survival, while the 60-month classifier predicts death.
Because of censoring it is necessary to apply some Boolean filters to the data in
order to correctly assess the resulting classifiers. To construct AUC curves for the 6
month classifier, we restrict ourselves to patients in the test data where either of the
following mutually exlusive conditions holds:
• survival months >= 6 AND vital status recode == 0
• vital status recode == 1
That is, we restrict ourselves to subsets of the data where we know for certain
whether or not the subject survived at least 6 months. Similarly for the 12 and 60
months surivival classifiers.
Survival Curve Error Estimates The following bootstrap method was used to
calculate the upper and lower bounds corresponding to 95% confidence intervals. From
equation (3), we can obtain the cumulative distribution function (CDF) associated with
each individual survival curve. We then sample from this CDF in a way that reflects the
underlying data used to produce the model. The training data used to create the model
has an underlying distribution of survival months. In the transformed training dataset,
each subject contributes as many rows as the number of survival months plus one
(patients with zero survival months still contribute one row to the training data). A
patient that survived 50 months contributes 51 “points” to the training of the model. If
all patients lived out to 107 months, the model would contain less uncertainty. This
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Figure 1. Example of the construction of the binary classifiers for 6, 12, and 60
months survival. A patient’s hazard curve λ(Xi, tj) is predicted by the model for times
out to 107 months. The survival curve is then readily computed as in Equation (3). For
this example, the 6-month and 12-month classifiers predict survival, while the 60-month
classifier predicts death.
observation leads to the following algorithm for determining the error estimates to the
predicted survival curves:
• compute the CDF associated with the survival curve
• use the underlying training data CDF of survival months to choose the number of
points to draw from the survival curve CDF, and compute a new survival curve
• Repeat the previous step 10,000 times and collect the curves into a list. Changing
the number of curves affects how smooth the upper and lower bounds are, but
does not affect the interval size between for each month.
• extract for each month from the list of curves the .975 and .025 percentiles to
record the values for the upper and lower curves
The process is analogous to the following hypothetical situation. Imagine a patient
going to an expert to get a survival prognosis. After collecting data on the patient and
keeping records, the expert predicts the central, single survival curve. The patient then
seeks multiple “second opinions.” These second opinions are generated not from
independent examinations of the patient, but by outside experts sampling from the data
already collected by the first expert. Then the predictions of 95% of these 10,000
experts all fall within the band determined by the upper and lower curves.
3.1 Performance Metrics
AUC scores The AUC scores for each of the 18 different binary classifiers are listed
in section (5.15). The lowest AUC in section (5.15) is .765, corresponding to the lung
neural network model predictions for 6 months survival, while the highest AUC in
section (5.15) is .885, corresponding to the breast random forest model predictions for
12 months survival.
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Model Agreement An additional means of validating the predictions of these
models is by comparing their predictions to each other for the same set of input data.
section (5.16) shows the strong agreement between the random forest and neural
network classifiers for each cancer type. Python code showing how the values in
section (5.16) are computed is available in the files NewPatientBreastCF.html ,
NewPatientColonCF.html , and NewPatientLung.html in the GitHub repository
containing supplemental matierial for this study [14]. Section (5.16) is computed as
follows. For each cancer type (breast,colon, and lung), do the following:
• use the corresponding Random Forest and Neural Network models to compute the
survival curves for all of the test subjects
• extract the values of the survival curve evaluted for 6, 12, and 60 months for both
models
• if both models predict less than .5 or both models predict greater than or equal to
.5, that counts as agreement
• otherwise, the models disagree
Fig. (2) shows scatter plots of the neural network and random forest predictions for
6, 12, and 60 month survival prediction for each cancer type. The correlations of the
neural network and random forest predictions are listed in section (5.17). Event though
breast cancer 6 month survival has the highest percentage agreement between the two
classifiers (over 99%), it also has the lowest correlation (.676). This seeming
contradiction is a result of the high 6-month survival rate for breast cancer, and that
the random forest and neural network models seem to treat this case differently. The
neural network models in general appear to be less pessimistic in general than the
random forest model predictions.
The high level of agreement between two models lends confidence to the notion that
they have both learned from the training data and are generalizing well.
3.2 Survival Curve Prediction Apps
The six models have their full hyperparameter and architecture presented in
sections (5.8, 5.9, 5.9, 5.10, 5.11, 5.12). Python code for all six model training and
evaluation is available at the githib respository containing supplemental material for
this study [14].
Using the popular Flask microframework for web applications [20], we have made
web applications corresponding to the six models. The list of web applications below
will allow readers to freely experiment with the models.
1. breast cancer
(a) random forest:
https://github.com/doolingdavid/breast-cancer-rf-errors.git
(b) neural network:
https://github.com/doolingdavid/breast-cancer-nn-errors.git
2. lung cancer
(a) random forest:
https://github.com/doolingdavid/lung-cancer-rf-errors.git
(b) neural network:
https://github.com/doolingdavid/lung-cancer-nn-errors.git
3. colon cancer
(a) random forest:
https://github.com/doolingdavid/colon-cancer-rf-errors.git
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Figure 2. Scatter plots showing the correlations between the MLP model’s prediction and RF model’s prediction for the
probablity of surviving at least 6, 12, and 60 months for the lung, colon and breast cancer test data.
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(b) neural network:
https://github.com/doolingdavid/colon-cancer-nn-errors.git
After downloading the .zip file associate with one of the above web applications, and
assuming python is installed on your system, you can launch the application by running
>python hello.py
and pointing the browser to the local server: http://127.0.0.1:5000 , or
http://localhost:5000 .
For example, using the Colon Cancer neural network app, and inputing the values
listed in section (5.18) results in the survival curve depicted in Figure (3); the predicted
probablities of living at least 6, 12, and 60 months are .89, .83, and .50, respectively.
Figure 3. Colon Cancer Survival Curve predicted from the data in section (5.18)
using the neural network web app
https://github.com/doolingdavid/colon-cancer-nn-errors.git.
Changing the data in section (5.18) so that the address field is changed from Boston,
Massachusetts to Denver, Colorado but keeping all other variables unchanged results in
the predicted probabilities of living at least 6, 12, and 60 months: .945, .902, .665.
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Behind the scenes, the apps use the input to the address field to make a call to the
Google Maps API to convert the address into a latitude, longitude and elevation. These
probablities are noticeably higher and reflect the documented effects of both longitude
and elevation on cancer treatment and prognosis in the United States [21].
A similar example of how changing the inputs to the models affects the predicted
survival curves in interesting ways can be seen with the random forest model for lung
cancer. Changing the data in section (5.19 by toggling between the male/female, and
married/single four possible permutations results in the following prediction probabilites
for 6, 12, and 60 month survival:
• male/married: .53, .27, .01
• male/single: .35, .18, .009
• female/married: .55, .31, .01
• female/single: .50, .27, .01
Inputting the same combinations of data into the lung cancer neural network app
https://github.com/doolingdavid/lung-cancer-nn-errors.git yields the
following probabilities:
• male/married: .42, .24, .04
• male/single: .40, .22, .03
• female/married: .44, .26, .04
• female/single: .42, .24, .04
It it interesting to note that both the random forest and neural network lung cancer
models predict greater 6 month survival rates for married people, with a slightly greater
benefit for males than females. The effect is greater in the random forest model, but is
also visible in the neural network model.
4 Discussion
The purpose of this study has been twofold; to develop a general methodology of data
transformation to survival data with censored observations so that machine learning
algorithms can be applied and to apply the methodology to create models of
personalized survival curve prognosis. To help further refine the methodology, we would
like to apply it to different survival datasets [22], not necessarily within the healthcare
domain. In particular, the methods presented in this paper do not take into account
time varying features. For example, the cs tumor size variable that has been a part
of this study is kept fixed at the value measured at diagnosis for all records
corresponding to a given subject. Clearly, the actual tumor size varies along with time
and a sophisitcated model can be developed to take this into account, given available
datasets.
The SEER database has been linked with claims data in the SEER-Medicare Linked
Database [23]. This linkage allows for the identification of additional clinical data for
each record in the SEER database and allows for an enrichment of the models presented
in this study, and is an avenue for further investigation.
An additional avenue of research concerns the broad concept of causality. As
demonstrated in section (3.2), there appears to be a correlation between marital status
and survival prognosis. Does this mean that if a single person in Boston, Massachusetts
is diagnosed with cancer, that they should immediately get married and move to
Denver? Of course not. But personal discussions with providers has confirmed for one
of the authors (D.D.) that married males tend to be much more diligent in following
instructions than their single counterparts. What appears to be in effect is that some of
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the SEER data is providing an identifiable signature of underlying causes not directly
represented by the data. Latent variables not directly seen in the data are still
providing echos of patterns in the data and the sheer volume allows us to see glimpses
of these patterns. Marital status is in some instances a surrogate for the presence of a
strong social structure and support group surrounding a patient, which presence
presumably leads to more desirable survival prognosis. The daunting and exciting task
of teasing out actual causality relationships within machine learning contexts has been
pioneeered by Judea Pearl of the University of California, Los Angeles and seems
particulary relevant and applicable to censored survival data. Combining the
methodology presented in this study with that of the pioneering work of Judea Pearl on
causality will be a fruitful avenue for future research.
5 Supporting Information
5.1 S1 Text
Raw SEER datafiles
• incidence\yr1973 2012.seer9\COLRECT.txt
• incidence\yr1973 2012.seer9\BREAST.txt
• incidence\yr1973 2012.seer9\RESPIR.txt
• incidence\yr1992 2012.sj la rg ak\COLRECT.txt
• incidence\yr1992 2012.sj la rg ak\BREAST.txt
• incidence\yr1992 2012.sj la rg ak\RESPIR.txt
• incidence\yr2000 2012.ca ky lo nj ga\COLRECT.txt
• incidence\yr2000 2012.ca ky lo nj ga\BREAST.txt
• incidence\yr2000 2012.ca ky lo nj ga\RESPIR.txt
• incidence\yr2005.lo 2nd half\COLRECT.txt
• incidence\yr2005.lo 2nd half\BREAST.txt
• incidence\yr2005.lo 2nd half\RESPIR.txt
5.2 S2 Text
A preprocessing step common to each of the three cancer types studied involves the
SEER STATE-COUNTY RECODE variable. The STATE-COUNTY RECODE field is a
state-county combination where the first two characters represent the state FIPS code
and the last three digits represent the FIPS county code. The FIPS code is a five-digit
Federal Information Processing Standard (FIPS) code which uniquely identifies counties
and county equivalents in the United States, certain U.S. possessions, and certain freely
associated states. This particular field illustrates an important characteristic of machine
learning, that is, the difference between categorical features and numeric features. All
input into a machine learning algorithm must be numeric, but real numbers carry with
them the usually extremely useful property known as the well-ordering property.
Machine learning algorithms use the well-ordering property of the real numbers to learn.
But if one is tasked with encoding a categorical feature into suitable numeric format for
machine learning, it is necessary to do so in a way that removes the well-ordering
property. Categorical variables are commonly encoded using one-hot encoding, in which
the explanatory variable is encoded using one binary feature for each of the variable’s
possible values [24].
One-hot encoding needs to be applied to all of the nominal categorical variables in
the SEER data that we wish to include in our predictive models. In particular, in order
to include the geophgraphical information contained in the SEER categorical variable
STATE-COUNTY RECODE , it becomes necessary to create a new feature variable for each
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of the distinct (state,county) pairs in the data. In the United States, there are
approximately 3,000 counties. Clearly, transforming the STATE-COUNTY RECODE data
representation into distinct (state county) columns will explode the dataset to become
wider than is optimal for machine learning. Adding extra columns to your dataset,
making it wider, requires more data rows (making it taller) in order for machine
learning algorithms to effectively learn [24]. Because one-hot coding
STATE-COUNTY RECODE would cause such drastic shape changes in our data, we wish
to avoid doing so. Fortunately, this variable, though given as a categorical variable, is
actually a recode for three ordinal variables. There is an ordering among the
(state county) columns, namely longitude, latitude, and elevation. We can transform the
data in STATE-COUNTY RECODE into three new numerical columns: lat , lng , and
elevation .
For example, section (5.20) shows how five entries of STATE-COUNTY RECODE
corresponding to counties within New Mexico can be represented by the elevation ,
lat , and lng features.
It is a simple exercise to construct the full lookup table from the SEER
STATE-COUNTY RECODE variable to the corresponding three values elevation ,
lat , and lng . We use the publically available datafile from the United States Census
Bureau [25] to map the state FIPS and county FIPS codes to query strings like those in
the address field in section (5.20). It is then possible to programmatically query the
Google Maps Geocoding API for the latitude and longitude [26], and the Google Maps
Elevation API for the corresponding elevation [27]. An added benefit of this shift from
the single categorical variable STATE-COUNTY RECODE to the three continuous
numerical variables lat , lng , and elevation is that input into the web
applications described later are not restricted to the states and counties coverered in the
SEER registries; in fact, the input to the models can be any address you would enter
into Google Maps and calls to the Google Maps Geocoding API and the Google Maps
Elevation API provide the conversion from the address string to the input variables
lat , lng , and elevation . The full lookup table analogous to section (5.20) is
available from a GitHub repository containing supplemental information for this
study [14].
5.3 S3 Text
The four COLRECT.txt files were imported into a pandas DataFrame object. This data
was then filtered according to the conditions in section (5.21). The RESPIR.txt and
BREAST.txt files were imported into separate dataframes in similar fashion and filtered
according to the conditions in section (5.22) and section (5.23), respectively. The SEER
variable CS TUMOR SIZE records the tumor size in millimeters if known. But if not
known, CS TUMOR SIZE is given as ’999’, to indicate that the tumor size is ”Unknown;
size not stated; not stated in pateint record.” In this study, we discard those records, as
indicated in sections (5.23, 5.21, 5.22).
The following categorical features were one-hot encoded for each of the three
datasets:
• SEX ,
• MARITAL STATUS AT DX ,
• RACE/ETHNICITY ,
• SPANISH/HISPANIC ORIGIN ,
• GRADE ,
• PRIMARY SITE ,
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• LATERALITY ,
• SEER HISTORIC STAGE A ,
• HISTOLOGY RECODE--BROAD GROUPINGS ,
• MONTH OF DIAGNOSIS ,
• VITAL STATUS RECODE ,
and the STATE-COUNTY RECODE variable was dropped and replaced with the
elevation , lat , and lng variables for all three datasets as illustrated in Table (??).
5.4 S4 Text
Colon Cancer Feature Selection The feature set used as input into both the
Random Forest and Neural Network models, after the transformation described in
section (2.2) is given below and also available in full detail in the file
NewPatientColonML.html .
• cs tumor size
• elevation
• grade cell type not determined
• grade moderately differentiated
• grade poorly differentiated
• grade undifferentiated; anaplastic
• grade well differentiated
• histology recode broad groupings acinar cell neoplasms
• histology recode broad groupings adenomas and adenocarcinomas
• histology recode broad groupings blood vessel tumors
• histology recode broad groupings complex epithelial neoplasms
• histology recode broad groupings complex mixed and stromal neoplasms
• histology recode broad groupings cystic, mucinous and serous neoplasms
• histology recode broad groupings ductal and lobular neoplasms
• histology recode broad groupings epithelial neoplasms, NOS
• histology recode broad groupings fibromatuos neoplasms
• histology recode broad groupings germ cell neoplasms
• histology recode broad groupings lipomatous neplasms
• histology recode broad groupings miscellaneous bone tumors
• histology recode broad groupings myomatous neoplasms
• histology recode broad groupings neuroepitheliomatous neoplasms
• histology recode broad groupings nevi and melanomas
• histology recode broad groupings paragangliomas and glumus tumors
• histology recode broad groupings soft tissue tumors and sarcomas, NOS
• histology recode broad groupings squamous cell neoplasms
• histology recode broad groupings synovial-like neoplasms
• histology recode broad groupings transistional cell papillomas and carcinomas
• histology recode broad groupings unspecified neoplasms
• lat
• laterality Left: origin of primary
• laterality Not a paired site
• laterality Only one side involved, right or left origin unspecified
• laterality Paired site, but no information concerning laterality; midline tumor
• laterality Right: origin of primary
• lng
• marital status at dx Divorced
• marital status at dx Married (including common law)
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• marital status at dx Separated
• marital status at dx Single (never married)
• marital status at dx Unknown
• marital status at dx Unmarried or domestic partner
• marital status at dx Widowed
• month of diagnosis Apr
• month of diagnosis Aug
• month of diagnosis Dec
• month of diagnosis Feb
• month of diagnosis Jan
• month of diagnosis Jul
• month of diagnosis Jun
• month of diagnosis Mar
• month of diagnosis May
• month of diagnosis Nov
• month of diagnosis Oct
• month of diagnosis Sep
• number of primaries
• race ethnicity Amerian Indian, Aleutian, Alaskan Native or Eskimo
• race ethnicity Asian Indian
• race ethnicity Asian Indian or Pakistani
• race ethnicity Black
• race ethnicity Chinese
• race ethnicity Fiji Islander
• race ethnicity Filipino
• race ethnicity Guamanian
• race ethnicity Hawaiian
• race ethnicity Hmong
• race ethnicity Japanese
• race ethnicity Kampuchean
• race ethnicity Korean
• race ethnicity Laotian
• race ethnicity Melanesian
• race ethnicity Micronesian
• race ethnicity New Guinean
• race ethnicity Other
• race ethnicity Other Asian
• race ethnicity Pacific Islander
• race ethnicity Pakistani
• race ethnicity Polynesian
• race ethnicity Samoan
• race ethnicity Thai
• race ethnicity Tongan
• race ethnicity Unknown
• race ethnicity Vietnamese
• race ethnicity White
• seer historic stage a Distant
• seer historic stage a In situ
• seer historic stage a Localized
• seer historic stage a Regional
• seer historic stage a Unstaged
• sex Female
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• spanish hispanic origin Cuban
• spanish hispanic origin Dominican Republic
• spanish hispanic origin Mexican
• spanish hispanic origin Non-Spanish/Non-hispanic
• spanish hispanic origin Other specified Spanish/Hispanic origin (excludes
Dominican Repuclic)
• spanish hispanic origin Puerto Rican
• spanish hispanic origin South or Central American (except Brazil)
• spanish hispanic origin Spanish surname only
• spanish hispanic origin Spanish, NOS; Hispanic, NOS; Latino, NOS
• spanish hispanic origin Uknown whether Spanish/Hispanic or not
• year of birth
• year of diagnosis
• month
and newtarget is the target variable, indicating whether or not the subject died in
month given by the value of the month variable.
5.5 S5 Text
Lung Cancer Feature Selection The feature set used as input into both the Random
Forest and Neural Network models, after the transformation described in section (2.2) is
given below and also available in full detail in the file NewPatientLungML.html .
• cs tumor size
• elevation
• grade cell type not determined
• grade moderately differentiated
• grade poorly differentiated
• grade undifferentiated; anaplastic
• grade well differentiated
• histology recode broad groupings acinar cell neoplasms
• histology recode broad groupings adenomas and adenocarcinomas
• histology recode broad groupings blood vessel tumors
• histology recode broad groupings complex epithelial neoplasms
• histology recode broad groupings complex mixed and stromal neoplasms
• histology recode broad groupings cystic, mucinous and serous neoplasms
• histology recode broad groupings ductal and lobular neoplasms
• histology recode broad groupings epithelial neoplasms, NOS
• histology recode broad groupings fibroepithelial neoplasms
• histology recode broad groupings fibromatuos neoplasms
• histology recode broad groupings germ cell neoplasms
• histology recode broad groupings gliomas
• histology recode broad groupings granular cell tumors & alveolar soft part
sarcomas
• histology recode broad groupings lipomatous neplasms
• histology recode broad groupings miscellaneous bone tumors
• histology recode broad groupings miscellaneous tumors
• histology recode broad groupings mucoepidermoid neoplasms
• histology recode broad groupings myomatous neoplasms
• histology recode broad groupings myxomatous neoplasms
• histology recode broad groupings nerve sheath tumors
• histology recode broad groupings neuroepitheliomatous neoplasms
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• histology recode broad groupings nevi and melanomas
• histology recode broad groupings osseous and chondromatous neoplasms
• histology recode broad groupings paragangliomas and glumus tumors
• histology recode broad groupings soft tissue tumors and sarcomas, NOS
• histology recode broad groupings squamous cell neoplasms
• histology recode broad groupings synovial-like neoplasms
• histology recode broad groupings thymic epithelial neoplasms
• histology recode broad groupings transistional cell papillomas and carcinomas
• histology recode broad groupings trophoblastic neoplasms
• histology recode broad groupings unspecified neoplasms
• lat
• laterality Bilateral involvement, lateral origin unknown; stated to be single
primary
• laterality Left: origin of primary
• laterality Not a paired site
• laterality Only one side involved, right or left origin unspecified
• laterality Paired site, but no information concerning laterality; midline tumor
• laterality Right: origin of primary
• lng
• marital status at dx Divorced
• marital status at dx Married (including common law)
• marital status at dx Separated
• marital status at dx Single (never married)
• marital status at dx Unknown
• marital status at dx Unmarried or domestic partner
• marital status at dx Widowed
• month of diagnosis Apr
• month of diagnosis Aug
• month of diagnosis Dec
• month of diagnosis Feb
• month of diagnosis Jan
• month of diagnosis Jul
• month of diagnosis Jun
• month of diagnosis Mar
• month of diagnosis May
• month of diagnosis Nov
• month of diagnosis Oct
• month of diagnosis Sep
• number of primaries
• race ethnicity Amerian Indian, Aleutian, Alaskan Native or Eskimo
• race ethnicity Asian Indian
• race ethnicity Asian Indian or Pakistani
• race ethnicity Black
• race ethnicity Chamorran
• race ethnicity Chinese
• race ethnicity Fiji Islander
• race ethnicity Filipino
• race ethnicity Guamanian
• race ethnicity Hawaiian
• race ethnicity Hmong
• race ethnicity Japanese
• race ethnicity Kampuchean
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• race ethnicity Korean
• race ethnicity Laotian
• race ethnicity Melanesian
• race ethnicity Micronesian
• race ethnicity New Guinean
• race ethnicity Other
• race ethnicity Other Asian
• race ethnicity Pacific Islander
• race ethnicity Pakistani
• race ethnicity Polynesian
• race ethnicity Samoan
• race ethnicity Thai
• race ethnicity Tongan
• race ethnicity Unknown
• race ethnicity Vietnamese
• race ethnicity White
• seer historic stage a Distant
• seer historic stage a In situ
• seer historic stage a Localized
• seer historic stage a Regional
• seer historic stage a Unstaged
• sex Female
• spanish hispanic origin Cuban
• spanish hispanic origin Dominican Republic
• spanish hispanic origin Mexican
• spanish hispanic origin Non-Spanish/Non-hispanic
• spanish hispanic origin Other specified Spanish/Hispanic origin (excludes
Dominican Repuclic)
• spanish hispanic origin Puerto Rican
• spanish hispanic origin South or Central American (except Brazil)
• spanish hispanic origin Spanish surname only
• spanish hispanic origin Spanish, NOS; Hispanic, NOS; Latino, NOS
• spanish hispanic origin Uknown whether Spanish/Hispanic or not
• year of birth
• year of diagnosis
• month
and newtarget is the target variable, indicating whether or not the subject died in
month given by the value of the month variable.
5.6 S6 Text
Breast Cancer Feature Selection The feature set used as input into both the
Random Forest and Neural Network models, after the transformation described in
section (2.2) is given below and also available in full detail in the file
NewPatientBreastML.html .
• cs tumor size
• elevation
• grade moderately differentiated
• grade poorly differentiated
• grade ndifferentiated; anaplastic
• grade well differentiated
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• histology recode broad groupings adenomas and adenocarcinomas
• histology recode broad groupings adnexal and skin appendage neoplasms
• histology recode broad groupings basal cell neoplasms
• histology recode broad groupings complex epithelial neoplasms
• histology recode broad groupings cystic, mucinous and serous neoplasms
• histology recode broad groupings ductal and lobular neoplasms
• histology recode broad groupings epithelial neoplasms, NOS
• histology recode broad groupings nerve sheath tumors
• histology recode broad groupings unspecified neoplasms
• lat
• laterality Bilateral involvement, lateral origin unknown; stated to be single
primary
• laterality Paired site, but no information concerning laterality; midline tumor
• laterality Right: origin of primary
• lng
• marital stats at dx Divorced
• marital stats at dx Married (inclding common law)
• marital stats at dx Separated
• marital stats at dx Single (never married)
• marital stats at dx Unknown
• marital stats at dx Unmarried or domestic partner
• marital stats at dx Widowed
• month of diagnosis Apr
• month of diagnosis Aug
• month of diagnosis Dec
• month of diagnosis Feb
• month of diagnosis Jan
• month of diagnosis Jul
• month of diagnosis Jun
• month of diagnosis Mar
• month of diagnosis May
• month of diagnosis Nov
• month of diagnosis Oct
• month of diagnosis Sep
• race ethnicity Amerian Indian, Aletian, Alaskan Native or Eskimo
• race ethnicity Asian Indian
• race ethnicity Black
• race ethnicity Chinese
• race ethnicity Japanese
• race ethnicity Melanesian
• race ethnicity Other
• race ethnicity Other Asian
• race ethnicity Pacific Islander
• race ethnicity Thai
• race ethnicity Unknown
• race ethnicity Vietnamese
• race ethnicity White
• seer historic stage a Distant
• seer historic stage a In sit
• seer historic stage a Localized
• seer historic stage a Unstaged
• sex Female
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• spanish hispanic origin Cuban
• spanish hispanic origin Mexican
• spanish hispanic origin Non-Spanish/Non-hispanic
• spanish hispanic origin Other specified Spanish/Hispanic origin (excldes
Dominican Republic)
• spanish hispanic origin Spanish surname only
• spanish hispanic origin Spanish, NOS; Hispanic, NOS; Latino, NOS
• year of birth
• year of diagnosis
• month
and newtarget is the target variable, indicating whether or not the subject died in
month given by the value of the month variable.
5.7 S7 Text
Pseudocode for the Data Transformation
def train(X, T, D)
// X, T, D are the original dataset
X’ = []
D’ = []
// the transformation
for each index i in X:
for t=1 to T[i]:
new_D = (0 if t < T[i], else D[i])
append new_D to D’
new_X = (X[i], t)
append new_X to X’
return a decision tree trained on (X’, D’)
def pmf(h, X)
// X is a single datapoint
// returns an array A where A[i] = P(Y = i | X)
A = []
p_so_far = 1 // this is p(T >= t | X)
for t = 1 to (the last month where h has any data):
// h knows p(T = t | T >= t, X), we call this p_cur
p_cur = h’s prediction for (X, t)
append (p_so_far * p_cur) to A
p_so_far *= (1 - p_cur)
5.8 S8 Text
Breast Random Forest Model Hyperparameters
rf = RandomForestClassifier(n_estimators=20,min_samples_split=3,
max_depth = 15,
max_features = .8,
n_jobs=5,verbose=2,random_state=33)
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5.9 S9 Text
Colon Random Forest Model Hyperparameters
rf = RandomForestClassifier(n_estimators=25,min_samples_split=3,
max_depth = 10,
max_features = .5,
n_jobs=5,verbose=2,random_state=3)
S10 Text
Lung Random Forest Model Hyperparameters
rf = RandomForestClassifier(n_estimators=25,min_samples_split=3,
max_depth = 11,
max_features = .8,
n_jobs=5,verbose=2,random_state=3)
5.10 S11 Text
Breast Neural Network Model Architecture The archictecture of the Keras
multilayer perceptron neural network model trained on the breast cancer data is given
explicitly below:
modelbreast = Sequential()
modelbreast.add(Dense(114, input_shape=(66,) ,init=’normal’))
modelbreast.add(Activation(’relu’))
modelbreast.add(Dropout(0.05))
modelbreast.add(Dense(50, init=’normal’))
modelbreast.add(Activation(’relu’))
modelbreast.add(Dropout(0.05))
modelbreast.add(Dense(36, init=’normal’))
modelbreast.add(Activation(’relu’))
modelbreast.add(Dropout(0.05))
modelbreast.add(Dense(2, init=’normal’))
modelbreast.add(Activation(’softmax’))
rms = RMSprop(lr=0.001)
modelbreast.compile(loss=’binary_crossentropy’,
optimizer=rms, class_mode="binary")
and trained with a batch size of 1500 for 200 epochs.
5.11 S12 Text
Colon Cancer Neural Network Model Architecture The archictecture of the
Keras multilayer perceptron neural network model trained on the colon cancer data is
given explicitly below:
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modelcolon = Sequential()
modelcolon.add(Dense(114, input_shape=(102,) ,init=’normal’))
modelcolon.add(Activation(’relu’))
modelcolon.add(Dropout(0.05))
modelcolon.add(Dense(50, init=’normal’))
modelcolon.add(Activation(’relu’))
modelcolon.add(Dropout(0.05))
modelcolon.add(Dense(35, init=’normal’))
modelcolon.add(Activation(’relu’))
modelcolon.add(Dropout(0.05))
modelcolon.add(Dense(2, init=’normal’))
modelcolon.add(Activation(’softmax’))
rms = RMSprop(lr=0.001)
modelcolon.compile(loss=’binary_crossentropy’,
optimizer=rms, class_mode="binary")
and trained with a batch size of 1500 for 200 epochs.
5.12 S13 Text
Lung Cancer Neural Network Model Architecture
The archictecture of the Keras multilayer perceptron neural network model trained
on the lung cancer data is given explicitly below:
modellung = Sequential()
modellung.add(Dense(114, input_shape=(114,) ,init=’normal’))
modellung.add(Activation(’relu’))
modellung.add(Dropout(0.1))
modellung.add(Dense(80, init=’normal’))
modellung.add(Activation(’relu’))
modellung.add(Dropout(0.1))
modellung.add(Dense(40, init=’normal’))
modellung.add(Activation(’relu’))
modellung.add(Dropout(0.1))
modellung.add(Dense(2, init=’normal’))
modellung.add(Activation(’softmax’))
rms = RMSprop(lr=0.001)
modellung.compile(loss=’binary_crossentropy’,
optimizer=rms, class_mode="binary")
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and trained with a batch size of 2000 for 50 epochs.
5.13 S1 Table
Examples of four columns in the untransformed dataset.
cs tumor size year of birth survival months vital status recode Dead
newindex
205 60 1951 3 1
306 40 1950 3 0
5.14 S2 Table
Example of four columns in the transformed dataset.
cs tumor size year of birth month newtarget
newindex
205 60 1951 0 0
205 60 1951 1 0
205 60 1951 2 0
205 60 1951 3 1
306 40 1950 0 0
306 40 1950 1 0
306 40 1950 2 0
306 40 1950 3 0
5.15 S3 Table
AUC values for the Random Forest and Neural Networks model binary
classifiers derived from the full survival curve predictions; see text for
details. The number of subjects that were used in the calculation of a
given AUC score are given in parenthesis after the score.
Model 6 Months AUC 12 Months AUC 60 Months AUC
Breast RF .846 (3035) .885 (2797) .844 (1392)
Breast NN .855 (3035) .867 (2797) .836 (1392)
Colon RF .804 (5281) .806 (5003) .828 (3232)
Colon NN .797 (5281) .804 (5003) .841 (3232)
Lung RF .772 (5019) .796 (4860) .874 (4143)
Lung NN .765 (5019) .796 (4860) .875 (4143)
5.16 S4 Table
Percentage agreement for the Random Forest and Neural Network
classifiers for 6, 12, and 60 month survival predictions on the test data for
each cancer type.
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Cancer Type % agreement 6 months % agreement 12 months % agreement 60 months
Colon .981 .971 .915
Breast .994 .984 .938
Lung .861 .883 .900
5.17 S5 Table
Correlations between the Random Forest and Neural Network classifiers
for 6, 12, and 60 month survival predictions on the test data for each
cancer type. The corresponding scatter plots are shown in Fig. (??).
Cancer Type 6 months 12 months 60 months
Lung .914 .946 .921
Colon .900 .923 .935
Breast .676 .72 .785
5.18 S6 Table
Example input data to the Colon Cancer neural network app
https://github.com/doolingdavid/colon-cancer-nn-errors.git.
Variable Value
What is the tumor size (mm) 300
What is the patient’s address? boston massachusetts
Grade moderately differentiated
Histology adenomas and adenocarcinomas
Laterality not a paired site
Martial Status at Dx Single, never married
Month of Diagnosis Jan
How many primaries 1
Race ethnicity White
seer historic stage a Regional
Gender Male
spanish hispanic origin Non-spanish/Non-hispanic
Year of Birth 1940
Year of Diagnosis 2010
5.19 S7 Table
Example input data to the Lung Cancer random forest app
https://github.com/doolingdavid/lung-cancer-rf-errors.git.
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Variable Value
What is the tumor size (mm) 500
What is the patient’s address? newark new jersey
Grade well differentiated
Histology acinar cell neoplasms
Laterality
bilateral involvement, lateral origin unknown;
stated to be single primary
Martial Status at Dx Married including common law
Month of Diagnosis Jan
How many primaries 1
Race ethnicity White
seer historic stage a Distant
Gender Female
spanish hispanic origin Non-spanish/Non-hispanic
Year of Birth 1970
Year of Diagnosis 2011
5.20 S8 Table
Example of the transformation of STATE-COUNTY RECODE to elevation , lat ,
and lng .
STATE-COUNTY RECODE address elevation lat lng
35001 Bernalillo+county+NM 5207.579772 35.017785 -106.629130
35003 Catron+county+NM 8089.242628 34.151517 -108.427605
35005 Chaves+county+NM 3559.931671 33.475739 -104.472330
35006 Cibola+county+NM 6443.415570 35.094756 -107.858387
35007 Colfax+county+NM 6147.749089 36.579976 -104.472330
5.21 S9 Table
Filters applied to the Colon Cancer data.
Column Filter
SEQUENCE NUMBER-CENTRAL 6= "Unspecified"
AGE AT DIAGNOSIS 6= "Unknown age"
BIRTHDATE-YEAR 6= "Unknown year of birth"
YEAR OF DIAGNOSIS ≥ 2004
SURVIVAL MONTHS FLAG = "1"
CS TUMOR SIZE EXT/EVAL 6= ""
CS TUMOR SIZE 6= 999
SEER RECORD NUMBER = 1
PRIMARY SITE = "LARGE INTESTINE, (EXCL. APPENDIX)"
SEQUENCE NUMBER-CENTRAL = 0
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5.22 S10 Table
Filters applied to the Lung Cancer data.
Column Filter
SEQUENCE NUMBER-CENTRAL 6= "Unspecified"
AGE AT DIAGNOSIS 6= "Unknown age"
BIRTHDATE-YEAR 6= "Unknown year of birth"
YEAR OF DIAGNOSIS ≥ 2004
SURVIVAL MONTHS FLAG = "1"
CS TUMOR SIZE EXT/EVAL 6= ""
CS TUMOR SIZE 6= 999
SEER RECORD NUMBER = 1
PRIMARY SITE = "LUNG & BRONCHUS"
SEQUENCE NUMBER-CENTRAL = 0
5.23 S11 Table
Filters applied to the Breast Cancer data.
Column Filter
SEQUENCE NUMBER-CENTRAL 6= "Unspecified"
AGE AT DIAGNOSIS 6= "Unknown age"
BIRTHDATE-YEAR 6= "Unknown year of birth"
YEAR OF DIAGNOSIS ≥ 2004
SURVIVAL MONTHS FLAG = "1"
CS TUMOR SIZE EXT/EVAL 6= " "
CS TUMOR SIZE 6= 999
SEER RECORD NUMBER = 1
SEQUENCE NUMBER-CENTRAL = 0
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